citalopram and homocysteine

citalopram has been researched along with homocysteine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Almeida, OP; Fenner, S; Flicker, L; Ford, AH; Hegarty, S; Hirani, V; McCaul, K; van Bockxmeer, F	1
Ahn, Y; Bae, KY; Hong, YJ; Jeong, MH; Kang, H; Kang, HJ; Kim, JM; Kim, SW; Moon, WJ; Shin, IS; Stewart, R; Yoon, JS	1
Cong, Y; Liu, H; Zhou, Y	1

Trials

2 trial(s) available for citalopram and homocysteine

Article	Year
The B-VITAGE trial: a randomized trial of homocysteine lowering treatment of depression in later life. Trials, 2010, Jan-25, Volume: 11 Topics: Age Factors; Antidepressive Agents; Biomarkers; Citalopram; Depression; Double-Blind Method; Drug Therapy, Combination; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Medication Adherence; Middle Aged; Psychiatric Status Rating Scales; Research Design; Severity of Illness Index; Time Factors; Treatment Outcome; Vitamin B 12; Vitamin B 6; Vitamin B Complex; Western Australia	2010
Predictive value of homocysteine for depression after acute coronary syndrome. Oncotarget, 2016, Oct-18, Volume: 7, Issue:42 Topics: Acute Coronary Syndrome; Adult; Aged; Antidepressive Agents; Biomarkers, Tumor; Citalopram; Depression; Double-Blind Method; Female; Follow-Up Studies; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Predictive Value of Tests; Republic of Korea	2016

Article

Year

The B-VITAGE trial: a randomized trial of homocysteine lowering treatment of depression in later life.

Trials, 2010, Jan-25, Volume: 11

Topics: Age Factors; Antidepressive Agents; Biomarkers; Citalopram; Depression; Double-Blind Method; Drug Therapy, Combination; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Medication Adherence; Middle Aged; Psychiatric Status Rating Scales; Research Design; Severity of Illness Index; Time Factors; Treatment Outcome; Vitamin B 12; Vitamin B 6; Vitamin B Complex; Western Australia

2010

Predictive value of homocysteine for depression after acute coronary syndrome.

Oncotarget, 2016, Oct-18, Volume: 7, Issue:42

Topics: Acute Coronary Syndrome; Adult; Aged; Antidepressive Agents; Biomarkers, Tumor; Citalopram; Depression; Double-Blind Method; Female; Follow-Up Studies; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Predictive Value of Tests; Republic of Korea

2016

Other Studies

1 other study(ies) available for citalopram and homocysteine

Article	Year
Folic acid ameliorates depression-like behaviour in a rat model of chronic unpredictable mild stress. BMC neuroscience, 2020, 01-15, Volume: 21, Issue:1 Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Behavior, Animal; Biogenic Monoamines; Brain; Citalopram; Depression; Disease Models, Animal; Folic Acid; Homocysteine; Male; Rats, Sprague-Dawley; Stress, Psychological	2020

Article

Year

Folic acid ameliorates depression-like behaviour in a rat model of chronic unpredictable mild stress.

BMC neuroscience, 2020, 01-15, Volume: 21, Issue:1

Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Behavior, Animal; Biogenic Monoamines; Brain; Citalopram; Depression; Disease Models, Animal; Folic Acid; Homocysteine; Male; Rats, Sprague-Dawley; Stress, Psychological

2020